Provided by Tiger Fintech (Singapore) Pte. Ltd.

Impinj

77.24
+14.7023.50%
Post-market: 78.000.7600+0.98%19:47 EDT
Volume:1.86M
Turnover:131.30M
Market Cap:2.20B
PE:55.57
High:77.63
Open:62.99
Low:60.97
Close:62.54
Loading ...

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) shows 51 percent reduction in risk of progression to active multiple myeloma for patients with high-risk smoldering multiple myeloma

PR Newswire
·
09 Dec 2024

At US$165, Is It Time To Put Impinj, Inc. (NASDAQ:PI) On Your Watch List?

Simply Wall St.
·
08 Dec 2024

Despite shrinking by US$379m in the past week, Impinj (NASDAQ:PI) shareholders are still up 564% over 5 years

Simply Wall St.
·
07 Dec 2024

3 Momentum Anomaly Picks as Labor Market Concerns Increase Volatility

Zacks
·
06 Dec 2024

Unpacking Q3 Earnings: Vishay Intertechnology (NYSE:VSH) In The Context Of Other Analog Semiconductors Stocks

StockStory
·
05 Dec 2024

3 Stocks to Buy From the Prospering Semiconductor Electronics Industry

Zacks
·
05 Dec 2024

5 Growth Stocks to Buy in December for Impressive Short-Term Upside

Zacks
·
04 Dec 2024

FormFactor Stock Plunges 10% in a Month: What Should You Do Now?

Zacks
·
29 Nov 2024

This Sector Leader On 300% Run Eyes Fresh Buy Point Amid Accelerating Earnings

Blockhead
·
28 Nov 2024

4 Top-Ranked Tech Stocks to Buy With More Than 100% Return YTD

Zacks
·
26 Nov 2024

Impinj Gains 18% in 3 Months: Is the Stock Worth Buying?

Zacks
·
25 Nov 2024

Analog Devices (ADI) Q3 Earnings Report Preview: What To Look For

StockStory
·
25 Nov 2024

Zacks.com featured highlights Doximity, Impinj and Innodata

Zacks
·
20 Nov 2024

3 Momentum Anomaly Stocks to Buy as Election Rally Fizzles

Zacks
·
19 Nov 2024

Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
16 Nov 2024

What To Expect From Skyworks Solutions’s (SWKS) Q3 Earnings

StockStory
·
11 Nov 2024

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO® / DARZALEX® as subcutaneous monotherapy for high-risk smoldering multiple myeloma

PR Newswire
·
08 Nov 2024

ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire
·
08 Nov 2024

Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates

GlobeNewswire
·
07 Nov 2024

Impinj to Participate in Upcoming Investor Conferences

Business Wire
·
07 Nov 2024